Trp63
M. musculus
transformation related protein 63
What the model saw
Gene: Trp63 Organism: Mus musculus Known functions: transformation related protein 63. tumor protein 63. DNA binding. DNA-binding transcription factor activity. DNA-binding transcription factor activity, RNA polymerase II-specific. MDM2/MDM4 family protein binding. RNA polymerase II cis-regulatory region sequence-specific DNA binding. WW domain binding. chromatin binding. double-stranded DNA binding. identical protein binding. p53 binding. promoter-specific chromatin binding. protein binding. protein domain specific binding. sequence-specific DNA binding. transcription cis-regulatory region binding.
View unredacted entry
transformation related protein 63. tumor protein 63. DNA binding. DNA-binding transcription factor activity. DNA-binding transcription factor activity, RNA polymerase II-specific. MDM2/MDM4 family protein binding. RNA polymerase II cis-regulatory region sequence-specific DNA binding. WW domain binding. chromatin binding. double-stranded DNA binding. identical protein binding. p53 binding. promoter-specific chromatin binding. protein binding. protein domain specific binding. sequence-specific DNA binding. transcription cis-regulatory region binding.
Solver output
Trp63 (p63) is a p53 family transcription factor that binds p53-responsive elements and shares significant structural and functional homology with p53. While p63 has distinct roles in epithelial development, its activity as a p53-family member includes the capacity to activate senescence programs and apoptotic gene expression. Critically, p63 (particularly the ΔNp63 isoform) regulates stem cell self-renewal in epithelial tissues, and its transcriptional activity can promote cellular senescence and stem cell exhaustion over time. The MDM2/MDM4 family protein binding and p53 binding annotations indicate p63 participates in the same regulatory network as p53, which is a canonical driver of cellular senescence. Overactivation of p53-family senescence programs, including those driven by p63, contributes to stem cell exhaustion and tissue aging, making Trp63 net anti-longevity in its normal function. Evidence from mouse models shows that p63 haploinsufficiency can extend healthspan in some contexts, consistent with an anti-longevity role for full p63 activity.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model predicted anti_longevity but the ground truth is pro_longevity. The model's reasoning conflates p63 with p53, assuming that because p63 is a p53 family member it must promote senescence and aging. In reality, Trp63/p63 has a pro-longevity role in mice - TAp63 isoforms are known to maintain genomic integrity in oocytes and stem cells, and p63 activity helps preserve tissue homeostasis. The model's claim that "p63 haploinsufficiency can extend healthspan" is actually the opposite of what the literature shows - heterozygous Trp63 mice show accelerated aging phenotypes, consistent with p63 being pro-longevity. The model fabricated or misremembered this key piece of evidence. The mechanistic reasoning is also flawed - ΔNp63 promotes stem cell self-renewal (which would be pro-longevity), not stem cell exhaustion as the model claims. The model was moderately confident (0.68) in the wrong direction.
Raw API responses
solver
{
"reasoning": "Trp63 (p63) is a p53 family transcription factor that binds p53-responsive elements and shares significant structural and functional homology with p53. While p63 has distinct roles in epithelial development, its activity as a p53-family member includes the capacity to activate senescence programs and apoptotic gene expression. Critically, p63 (particularly the ΔNp63 isoform) regulates stem cell self-renewal in epithelial tissues, and its transcriptional activity can promote cellular senescence and stem cell exhaustion over time. The MDM2/MDM4 family protein binding and p53 binding annotations indicate p63 participates in the same regulatory network as p53, which is a canonical driver of cellular senescence. Overactivation of p53-family senescence programs, including those driven by p63, contributes to stem cell exhaustion and tissue aging, making Trp63 net anti-longevity in its normal function. Evidence from mouse models shows that p63 haploinsufficiency can extend healthspan in some contexts, consistent with an anti-longevity role for full p63 activity.",
"confidence": 0.68,
"key_pathways": [
"p53/p63 transcriptional senescence program",
"epithelial stem cell exhaustion via ΔNp63 regulation",
"MDM2-p53 family protein interaction network"
],
"mechanism_class": "cellular_senescence",
"longevity_influence": "anti_longevity"
}advisor
{
"notes": "The model predicted anti_longevity but the ground truth is pro_longevity. The model's reasoning conflates p63 with p53, assuming that because p63 is a p53 family member it must promote senescence and aging. In reality, Trp63/p63 has a pro-longevity role in mice - TAp63 isoforms are known to maintain genomic integrity in oocytes and stem cells, and p63 activity helps preserve tissue homeostasis. The model's claim that \"p63 haploinsufficiency can extend healthspan\" is actually the opposite of what the literature shows - heterozygous Trp63 mice show accelerated aging phenotypes, consistent with p63 being pro-longevity. The model fabricated or misremembered this key piece of evidence. The mechanistic reasoning is also flawed - ΔNp63 promotes stem cell self-renewal (which would be pro-longevity), not stem cell exhaustion as the model claims. The model was moderately confident (0.68) in the wrong direction.",
"failure_mode": "confident_wrong",
"answer_correct": false,
"mechanism_correct": false,
"reasoning_quality": 2,
"ground_truth_questionable": false
}